{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Promoting Treatment for Hepatitis C in People Who Inject Drugs: A Review of the Barriers and Opportunities

Activity Steps

Purpose of Activity

To present a literature review providing information about the perceived barriers associated with people who inject drugs (PWID) in receiving hepatitis C virus treatment and supporting recommendations for addressing these barriers.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Recall the background information relating to hepatitis C treatment in PWID.
  2. Summarize the results of the review of hepatitis C treatment in PWID.
  3. Outline recommendations for the treatment of hepatitis C for PWID.
Price: $12.95


  • AANP 1.0 CH / 0.33 APH
  • DC - BON 1.0 CH
  • FL - BON 1.0 CH
  • GA - BON 1.0 CH

This Activity is approved for 1.0 contact hour (s) of continuing education (which includes .33 hour(s) pharmacology) by the American Association of Nurse Practitioners. Activity ID# 20064287. This Activity was planned in accordance with AANP Accreditation Standards and Policies.

Awarded Advanced Pharmacology Hours

Test Code: JAANP0820
Published: Aug 2020
Expires: 9/1/2021
Required Passing Score: 13/18 (72%)
Authors: Annie Pedlar, DNP, RN; Prabjot (Jodie) Sandhu, DNP, FNP-C, PA-C, CNL